Skip to content
GLP-1 Scorecard
Menu
Graded #9

Sunlight.com

One of the cheapest published rates on the board — semaglutide $88/mo, tirzepatide $157/mo, flat and stated never to rise — from a LegitScript-certified telehealth with two named, NPI-verified physicians.

Visit Sunlight.comWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$88/mo
Tirzepatide
$157/mo
Coverage
All 50 states
Brand-name
Compounded only

Weigh Sunlight.com against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because Sunlight.com dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value92/100
Dose & formulation78/100
Clinical oversight86/100
Labs & monitoring80/100
Fulfillment88/100
Contract terms88/100

Strengths

  • Cheapest published semaglutide on this board ($88/mo) with competitively priced tirzepatide ($157/mo), both flat and stated to never increase — not quiz-gated, the FAQ states the exact figures
  • LegitScript-certified with two named physicians and public NPI numbers (Lion MD network), rather than an anonymous "licensed clinicians" claim
  • No membership fee, cancel anytime, free shipping in 1-2 days, a fresh 4-week supply every month
  • All 50 states served, plus a separate live NAD+ program on the same domain

Where it loses points

  • Injection only — the hero banner's "Injections and oral options available" line does not match the live site: no oral GLP-1 product page exists and sunlight.com/oral-semaglutide/ 404s
  • The $157 tirzepatide figure sits inside a collapsed FAQ accordion rather than the hero, so it takes one extra click to find even though it is genuinely on the page
  • Sermorelin is marketed as "launching soon" and is not yet live — do not expect it today
  • No published lab or monitoring cadence, and the compounding pharmacy partner is referenced only generically, not named

Bottom line — Grade B

Best for: Cost-conscious patients who want a clearly published flat price on both molecules and named clinicians behind the prescription, and who don't need an oral route or brand-name option.

Ranked #9 of 501 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest Sunlight.com — the realistic shortlist.

The 18 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect Sunlight.com's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Sunlight.com's site. Not medical advice; see our disclosure.

← Back to the scorecard